Healthcare

South Korea emphasises human accountability in medical AI

A South Korean health-policy discussion stressed investment in AI research and infrastructure while reserving final medical responsibility for humans.

South Korea’s health-policy discussion at the fifth World Bio Summit included the position that human beings must retain final judgment and responsibility for medical AI. The discussion covered AI training and technology development, expanded research and development, and infrastructure investment aimed at addressing unmet medical needs. It also prioritized human safety and dignity. The emphasis is significant for healthcare organizations adopting machine-learning tools because it places clinical accountability with people rather than systems, even as AI capabilities expand. The source presents AI as a technology requiring investment in research and infrastructure, not simply software procurement. This has practical implications for hospitals and health authorities considering decision-support, diagnostic or administrative applications: implementation must be tied to safety, responsible use and human oversight. The report does not identify a specific clinical product, deployment or measured patient outcome. Instead, it captures a policy and technology direction in which AI development is linked to unmet medical needs and training. For MENA health systems, the message is relevant to governance and workforce preparation, particularly where institutions are developing national digital-health programs and considering how clinicians should supervise AI-generated recommendations.

Original source: MoneyToday

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI